KINNATE BIOPHARMA INC

CUSIP: 49705R105 Class: Common Stock

CITADEL ADVISORS LLC's Holding History (CIK: 0001423053)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 214,664 Value ($000) $571 Avg Close — Range —
Q4 2023
Shares 415,842 Value ($000) $986 Avg Close — Range —
Q3 2023
Shares 1,059,843 Value ($000) $1,484 Avg Close — Range —
Q2 2023
Shares 1,086,386 Value ($000) $3,292 Avg Close — Range —
Q1 2023
Shares 1,073,549 Value ($000) $6,710 Avg Close — Range —
Q4 2022
Shares 1,103,374 Value ($000) $6,731 Avg Close — Range —
Q3 2022
Shares 1,096,301 Value ($000) $13,101 Avg Close — Range —
Q2 2022
Shares 1,127,389 Value ($000) $14,217 Avg Close — Range —
Q1 2022
Shares 1,133,054 Value ($000) $12,758 Avg Close — Range —
Q4 2021
Shares 1,121,704 Value ($000) $19,876 Avg Close — Range —
Q3 2021
Shares 1,154,273 Value ($000) $26,571 Avg Close — Range —
Q2 2021
Shares 1,300,887 Value ($000) $30,285 Avg Close — Range —
Q1 2021
Shares 1,315,650 Value ($000) $40,996 Avg Close — Range —
Q4 2020
Shares 1,315,500 Value ($000) $52,331 Avg Close — Range —